Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

RDW can be a useful marker for inflammation in alopecia areata patients.

A new mouse model helps understand and find treatments for alopecia areata.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Alopecia areata is an autoimmune disease causing hair loss, linked to immune and gut issues, needing more research for better treatments.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Trichoscopy helps quickly identify autoimmune diseases on the scalp but should be used with other standard tests.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Immune cells might contribute to hair loss caused by a specific mutation.

A dog's chronic bite wound healed successfully using a mix of herbal gel, low power laser, and ozone therapy.

The patient with Ankylosing Spondylitis had shoulder joint damage and bone changes.

Dupilumab may help treat alopecia areata without needing high IgE levels.

A mutation in mice causes hair loss and skin issues due to a defect in a gene affecting cell adhesion.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Alopecia areata may be treated by targeting immune system imbalances.

Testosterone therapy significantly improved Hidradenitis Suppurativa symptoms.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Severe alopecia areata in children can signal future autoimmune issues.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Immunotherapy helped a 5-year-old boy regrow hair and prevent seasonal alopecia areata.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.